• Source: HU6

HU6 is a controlled metabolic accelerator of the mitochondrial uncoupler 2,4-dinitrophenol (DNP) that is intended to "minimize the rapid absorption and high peak blood concentrations of DNP to provide a wider therapeutic index and improve safety." Developed by Rivus Pharmaceuticals, the drug is tested to reduce weight and liver fat in humans with risk factors for metabolic dysfunction-associated steatohepatitis. In a phase 2a trial, the higher dosage levels reduced liver fat on average by more than 30 percent and also reduced body weight significantly. A phase 2b trial was launched in late 2023.




References

Kata Kunci Pencarian:

• Daftar planet minor: 77001–78000
• Daftar planet minor/77401–77500
• HU6
• 2,4-Dinitrophenol
• List of postcode districts in the United Kingdom
• List of minor planets: 42001–43000
• List of minor planets: 33001–34000
• List of minor planets: 343001–344000
• List of minor planets: 671001–672000
• Sir Henry Cooper School
• List of minor planets: 581001–582000
• HU postcode area